| Serial Number | 85619481 |
| Word Mark | SOLCO HEALTHCARE U.S. |
| Filing Date | Tuesday, May 8, 2012 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, September 11, 2020 |
| Registration Number | 4478651 |
| Registration Date | Tuesday, February 4, 2014 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 5, 2013 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "HEALTHCARE U.S." |
| Goods and Services | Analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; antimicrobial preservatives for cosmetics and pharmaceuticals; pharmaceutical astringents; balms for pharmaceutical purposes; cream of tartar for pharmaceutical purposes; creosote for pharmaceutical purposes; dermatological pharmaceutical products; digestives for pharmaceutical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; ferments for pharmaceutical purposes; inhaled pharmaceutical preparations for the treatment of respiratory disease; injectable pharmaceuticals for treatment of anaphylactic reactions; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; iodine for pharmaceutical purposes; liquorice for pharmaceutical purposes; menthol for pharmaceutical purposes; pharmaceutical antitussive-cold preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, injectable contraceptives; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating hypertension; pharmaceutical products for treating respiratory disease and asthma; pharmaceutical products for the treatment of joint disease; plant extracts for medical, veterinary and pharmaceutical purposes; potassium preparations for pharmaceutical purposes; pharmaceutical preparations and substances for weight loss; vitamin and mineral supplements for use as ingredients in the food and pharmaceutical industry; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of coatings for facilitating the delivery of a wide range of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; biological preparations for the treatment of cancer and autoimmune deficiencies and disorders; pharmaceutical, veterinary and sanitary preparations, namely, conjugates of organic and inorganic chemicals with polypeptides, proteins, artificial polypeptides, artificial proteins produced by genetic engineering and for the treatment of viral and infectious diseases, immune system disorders, cancer, diabetes, cardiovascular diseases, central nervous system disorders and diseases; anti-diabetic pharmaceuticals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for treating skin disorders; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer |
| Goods and Services | Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies |
| Goods and Services | Medical and pharmaceutical consultation |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, September 11, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, June 3, 2009 |
| First Use In Commerce Date | Wednesday, June 3, 2009 |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, September 11, 2020 |
| Primary Code | 035 |
| First Use Anywhere Date | Friday, December 31, 2010 |
| First Use In Commerce Date | Friday, December 31, 2010 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, September 11, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | Friday, December 31, 2010 |
| First Use In Commerce Date | Friday, December 31, 2010 |
| Party Name | Solco Healthcare US, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cranbury, NJ 08512 |
| Party Name | Solco Healthcare US, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cranbury, NJ 08512 |
| Party Name | Solco Healthcare US, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cranbury, NJ 08512 |
| Event Date | Event Description |
| Friday, September 11, 2020 | CANCELLED SEC. 8 (6-YR) |
| Monday, February 4, 2019 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, February 4, 2014 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, December 31, 2013 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Saturday, December 28, 2013 | LAW OFFICE REGISTRATION REVIEW COMPLETED |
| Friday, December 27, 2013 | ASSIGNED TO LIE |
| Monday, December 23, 2013 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Monday, December 23, 2013 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, December 19, 2013 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, December 19, 2013 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, December 19, 2013 | SU-EXAMINER'S AMENDMENT WRITTEN |
| Thursday, November 21, 2013 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, November 21, 2013 | NON-FINAL ACTION E-MAILED |
| Thursday, November 21, 2013 | SU - NON-FINAL ACTION - WRITTEN |
| Sunday, November 10, 2013 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, October 30, 2013 | USE AMENDMENT FILED |
| Wednesday, October 30, 2013 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, August 28, 2013 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, August 26, 2013 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, August 5, 2013 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, April 30, 2013 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 5, 2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 5, 2013 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 13, 2013 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 29, 2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, January 25, 2013 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, January 24, 2013 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, January 24, 2013 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, January 24, 2013 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, January 24, 2013 | EXAMINERS AMENDMENT -WRITTEN |
| Saturday, January 5, 2013 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, January 5, 2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 27, 2012 | ASSIGNED TO LIE |
| Wednesday, December 19, 2012 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 5, 2012 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 5, 2012 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 5, 2012 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 29, 2012 | ASSIGNED TO EXAMINER |
| Tuesday, May 15, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, May 11, 2012 | NEW APPLICATION ENTERED IN TRAM |